The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for July 13, 2018
Copyright © Brakke Consulting, Inc.

Editor: Lynn Fondon DVM MBA

Brakke Consulting news
Transaction Assistance
Pain Management Products in Dogs and Cats

earnings news
True Leaf Medicine

other news
Blue Buffalo
Boehringer Ingelheim
Bovie Medical
Kindred Biosciences
Royal De Heus
Specialty Surgical Instrumentation


Let Brakke Consulting provide assistance for all your transactions.

Brakke Consulting has been the finder of record, agent of record or consultant for a number of successfully completed projects. We assist with valuations and provide due diligence on confidential transactions as well as offering executive counsel on a number of potential transactions.

Brakke Consulting has the experience, insight, ability and contacts to provide clients with the highest quality services in the animal health, pet, veterinary and specialty chemicals markets. Please contact any of our offices for a confidential consultation.


• Cargill reported results for the fiscal year ended May 31, 2018. Revenues grew 5% to $115 billion. Net earnings were $3.1 billion, a 9% increase compared to the prior year. Animal Nutrition & Protein surpassed last year’s strong results, making the segment the largest contributor to Cargill’s adjusted operating earnings in the full year. (company website)

• True Leaf Medicine International Ltd., announced results for its fiscal year ending March 31, 2018. Sales were C$1.4 million (US$1.1 million), a 280% over the previous fiscal year. Revenue growth was primarily fueled by True Leaf expanding the reach of its True Leaf Pet division to new locations in-store and online. (


• Virbac Corporation announced the launch of C.E.T. Veggiedent FR3SH Tartar Control Chews for Dogs, which uniquely targets bad breath while supporting proper digestion. (company press release)

• Norbrook Laboratories announced the launch of Eprizero (eprinomectin) Pour-on. Eprizero contains the same active ingredient and dosing regimen and has demonstrated bioequivalence in the target species to Eprinex. (Vet Advantage)

• Blue Buffalo Co. announced the launch of W+M Weight Management + Mobility Support for dogs, a therapeutic diet formulated to support canine weight loss and mobility. It is Blue’s second veterinary-exclusive diet formulated to fight pet obesity. (Todays Veterinary Business)

• Kindred Biosciences announced that Mirataz (mirtazapine transdermal ointment) for the management of weight loss in cats is commercially available to veterinarians in the United States. (PRNewswire)

• Bovie Medical Corporation announced that it has entered into a definitive agreement with Specialty Surgical Instrumentation Inc., a subsidiary of Symmetry Surgical Inc., to divest and sell the core business segment and the Bovie brand to Symmetry for gross proceeds of $97 million in cash. The company is retaining its Advanced Energy and OEM businesses, its facilities in Clearwater, FL and Sofia, Bulgaria, and certain intellectual property related to specialty generators. (Vet Advantage)

• FRANCE Boehringer Ingelheim announced an investment of over EUR 200 million ($235 million) to establish a new vaccine production center France’s Rhône-Alpes region. The investment is a record one-off investment by the company in its animal health division’s production network, and will enable the firm to respond to growing global demand for the control of foot-and-mouth disease (FMD) and Bluetongue virus. (Animal Pharm)

• ISRAEL Nutreco announced it has acquired a meaningful minority share in Israeli start-up ViAqua to aid development of an orally administered particle-based treatment platform that improves resistance to viral diseases in shrimp. The firm is currently focused on developing its technology to combat white spot syndrome virus (WSSV). Nutreco’s aquaculture division Skretting will work with ViAqua to bring its treatments to market. (Animal Pharm)

• SERBIA Royal De Heus announced that it signed an agreement for the acquisition of compound feed plant Komponenta in Serbia, giving the company two production locations in Serbia. Financial terms were not disclosed. (Feedstuffs)

• SWEDEN Intervacc announced it has received funding from the Eurostars-2 program to aid development of a vaccine against Streptococcus suis in pigs. The funding represented around 50% of the budgeted project cost of EUR 1.6 million ($1.87 million). Intervacc has been working with Moredun Scientific in Edinburgh on the INV274 project to develop a vaccine against S suis. (Animal Pharm)


• US – CANINE HEART DISEASE The FDA is alerting pet owners and veterinary professionals about reports of canine dilated cardiomyopathy (DCM) in dogs eating certain pet foods containing peas, lentils, other legume seeds, or potatoes as main ingredients. These reports are unusual because DCM is occurring in breeds not typically genetically prone to the disease. High levels of legumes or potatoes appear to be more common in diets labeled as “grain-free,” but it is not yet known how these ingredients are linked to cases of DCM. The FDA’s Center for Veterinary Medicine and the Veterinary Laboratory Investigation and Response Network, a collaboration of government and veterinary diagnostic laboratories, are investigating this potential association. (FDA)

• WORLD – DOG GENETICS The International Collaboration for Dog Health and Welfare (IPFD) announced the launch of, a database to provide guidance on the appropriate selection and use of genetic tests in dogs. The open-access database was launched as part of the Harmonization of Genetic Testing for Dogs initiative. (JAVMA)

• US – VETERINARY COLLEGES The colleges of veterinary medicine at Tuskegee and Auburn universities recently signed a memorandum of understanding that has created a specific partnership between the two. Under the agreement, Tuskegee will pay for one of its students to train at Auburn as a resident in an area of need, then return to Tuskegee as a veterinary medicine faculty member and board-certified specialist. The idea for this arrangement grew out of a discussion the two deans had about increasing diversity in the veterinary profession by training under-represented groups as board-certified specialists. Both deans are hopeful the agreement opens the door for other students to have similar opportunities. (

• US – DOG PARK The Jacksonville Jaguars announced they are building the first-ever dog park in a National Football League stadium. The Jaguars will debut their new Pet Paradise Park on August 9. It will feature artificial turf grass and a 5,000-gallon bone-shaped swimming pool along with plenty of fans and misters to keep all the visitors cool. There will even be a veterinarian available if needed. (Vet Advantage – AAHA NEWStat)

• US – BEE HEALTH Maryland Department of Agriculture’s chief apiary inspector trained her Labrador retriever to detect hives affected by American foulbrood bacteria. Unlike human inspectors, dogs don’t need the hives opened up to check them for foulbrood. She recently received a grant through the federal farm bill to expand her canine detection program, which could serve as a model for other states. (AVMA SmartBrief – New York Times)


Pain management is one of the leading topics in veterinary medicine today. Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
– overview of acute and chronic pain in small animals
– review of new products, including Galliprant and Nocita
– estimates of US sales and prices of leading products
– pain management products in development
– review of nutritional supplements used for chronic pain
– the use of cannabinoids in veterinary medicine
– review of therapeutic diets for joint care
– 2018 survey of 360 small animal veterinarians regarding use of pain management products

Pain Management Products for Dogs and Cats 2018 is available for immediate shipping for $5,750. Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at 972-243-4033, or email


The heat of the summer and planning activities for 2019 are having an impact on the number of stories to report this week. One does have to be impressed with the continued growth of Cargill in 2017-2018. Growing 5% year-over-year in a $100 billion business is not an easy task, particularly in some of the commodity areas where they operate.

Two of the new products announced this week are related to weight management in pets. It has become reasonably clear that pets in the US, like many of their owners, are experiencing excellent food and insufficient exercise to keep weight under control. We continue to believe that weight control in pets will be of increasing importance in the health of pets and we expect to see additional product introductions, both nutritional and drug related, introduced in the future.

For those of you attending the annual AVMA meeting in Denver have a great meeting. We will have two consultant in attendance to assist with any consulting needs you might have for us.

Have a great weekend and stay cool!

Ron Brakke

This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at

Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX 75234 USA

en_USEnglish (United States)